Biotechnology company Pluri Inc. has been granted a new U.S. patent for a novel method for expansion of immune cells using proprietary technology. How It Works Pluri’s proprietary 3D cell expansion technology mimics the natural lymph node-like environment that immune cells have within the human body. The tightly controlled and fully automated bioreactor system provides cells with the conditions they need to expand, enabling efficient expansion of immune cells at scale and quality.   This ...